Simon J. Dovedi

4.6k total citations · 1 hit paper
60 papers, 2.8k citations indexed

About

Simon J. Dovedi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Simon J. Dovedi has authored 60 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 43 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Simon J. Dovedi's work include Cancer Immunotherapy and Biomarkers (38 papers), Immunotherapy and Immune Responses (24 papers) and Immune Cell Function and Interaction (21 papers). Simon J. Dovedi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (38 papers), Immunotherapy and Immune Responses (24 papers) and Immune Cell Function and Interaction (21 papers). Simon J. Dovedi collaborates with scholars based in United Kingdom, United States and Singapore. Simon J. Dovedi's co-authors include Tim Illidge, Robert W. Wilkinson, Jamie Honeychurch, Eleanor J. Cheadle, Edmund Poon, Ross Stewart, Amy L. Adlard, Ian J. Stratford, Michelle Morrow and Grazyna Lipowska‐Bhalla and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Simon J. Dovedi

57 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

2014 974 citations Simon J. Dovedi, Amy L. Adlard et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon J. Dovedi United Kingdom	24	2.0k	1.4k	578	416	308	60	2.8k
Sofia R. Gameiro United States	28	1.9k 0.9×	1.5k 1.1×	556 1.0×	609 1.5×	157 0.5×	59	2.7k
Diego Chowell United States	16	2.2k 1.1×	1.4k 1.0×	790 1.4×	877 2.1×	329 1.1×	37	3.3k
Jonathan J. Havel United States	13	1.9k 0.9×	1.1k 0.8×	683 1.2×	825 2.0×	222 0.7×	14	2.7k
Yuru Meng United States	15	3.0k 1.5×	2.7k 2.0×	654 1.1×	856 2.1×	239 0.8×	18	4.4k
Karsten A. Pilones United States	16	1.4k 0.7×	1.1k 0.8×	342 0.6×	449 1.1×	96 0.3×	41	2.0k
Marlon C. Rebelatto United States	26	2.1k 1.1×	819 0.6×	874 1.5×	468 1.1×	798 2.6×	75	3.3k
Michael A. Postow United States	15	3.0k 1.5×	1.7k 1.2×	680 1.2×	726 1.7×	229 0.7×	18	3.9k
Rom S. Leidner United States	27	2.4k 1.2×	1.5k 1.1×	576 1.0×	965 2.3×	475 1.5×	94	3.7k
Christopher R. Heery United States	32	2.5k 1.2×	1.7k 1.2×	854 1.5×	876 2.1×	263 0.9×	112	3.8k
Ninke Leffers Netherlands	21	1.7k 0.9×	1.6k 1.1×	236 0.4×	363 0.9×	198 0.6×	26	2.5k

Countries citing papers authored by Simon J. Dovedi

Since Specialization

Citations

This map shows the geographic impact of Simon J. Dovedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon J. Dovedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon J. Dovedi more than expected).

Fields of papers citing papers by Simon J. Dovedi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon J. Dovedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon J. Dovedi. The network helps show where Simon J. Dovedi may publish in the future.

Co-authorship network of co-authors of Simon J. Dovedi

This figure shows the co-authorship network connecting the top 25 collaborators of Simon J. Dovedi. A scholar is included among the top collaborators of Simon J. Dovedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon J. Dovedi. Simon J. Dovedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Colin Y.C., Isaac Dean, Nathan Richoz, et al.. (2025). In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade. Cancer Immunology Research. 13(9). 1453–1470.

Walker, Jennifer A., Michelle Morrow, Viia Valge-Archer, et al.. (2023). Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and impact response to immuno-oncology treatments. Frontiers in Immunology. 14. 1258291–1258291. 9 indexed citations

Ball, Kathryn, Simon J. Dovedi, Pavan Vajjah, & Alex Phipps. (2023). Strategies for clinical dose optimization of T cell-engaging therapies in oncology. mAbs. 15(1). 2181016–2181016. 41 indexed citations

Kennedy, Alan, Claudia Hinze, Erin Waters, et al.. (2023). The CTLA ‐4 immune checkpoint protein regulates PD‐L1 : PD ‐1 interaction via transendocytosis of its ligand CD80. The EMBO Journal. 42(5). e111556–e111556. 14 indexed citations

Dovedi, Simon J., Viia Valge-Archer, Amit Grover, et al.. (2023). Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma. Cancer Immunology Research. 11(8). 1125–1136. 2 indexed citations

Graziano, Vincenzo, Andreas Dannhorn, Heather Hulme, et al.. (2023). Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. Journal for ImmunoTherapy of Cancer. 11(8). e006457–e006457. 10 indexed citations

Li, Zhi, Zewen Kelvin Tuong, Isaac Dean, et al.. (2022). In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue. The Journal of Experimental Medicine. 219(6). 63 indexed citations

Hair, James, Matthew J. Robinson, Robert W. Wilkinson, & Simon J. Dovedi. (2022). Deep phenotyping of surface stimulatory and inhibitory co-receptors on cancer-resident T and NK cells reveals cell subsets within the tumor-reactive CTL population that are uniquely defined by NKG2A expression. SLAS DISCOVERY. 27(2). 95–106. 1 indexed citations

Nakamura, Kyoko, Ankur Karmokar, Paul Farrington, et al.. (2021). Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control. Clinical Cancer Research. 27(15). 4353–4366. 43 indexed citations

10.

Harper, James A., Shannon Burke, Jon Travers, et al.. (2021). Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity. Molecular Cancer Therapeutics. 20(9). 1723–1734. 10 indexed citations

11.

Ambler, Rachel, Alan J. Hedges, Simon J. Dovedi, et al.. (2020). PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor. Science Signaling. 13(649). 10 indexed citations

12.

Dovedi, Simon J., Eleanor J. Cheadle, Edmund Poon, et al.. (2017). Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade. Clinical Cancer Research. 23(18). 5514–5526. 263 indexed citations

13.

Poon, Edmund, Stefanie Mullins, Amanda Watkins, et al.. (2017). The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment. Journal for ImmunoTherapy of Cancer. 5(1). 63–63. 59 indexed citations

14.

Dovedi, Simon J., Grazyna Lipowska‐Bhalla, Stephen A. Beers, et al.. (2016). Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells. Cancer Immunology Research. 4(7). 621–630. 44 indexed citations

15.

Murata, Masashi, Simon J. Dovedi, Robert W. Wilkinson, et al.. (2015). TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice. Cancer Immunology Immunotherapy. 64(10). 1229–1239. 19 indexed citations

16.

Dovedi, Simon J., Amy L. Adlard, Grazyna Lipowska‐Bhalla, et al.. (2014). Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade. Cancer Research. 74(19). 5458–5468. 974 indexed citations breakdown →

17.

Melis, Monique, K L Simpson, Simon J. Dovedi, et al.. (2013). Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death and Differentiation. 20(5). 765–773. 16 indexed citations

18.

Cheadle, Eleanor J., et al.. (2010). Natural Expression of the CD19 Antigen Impacts the Long-Term Engraftment but Not Antitumor Activity of CD19-Specific Engineered T Cells. The Journal of Immunology. 184(4). 1885–1896. 61 indexed citations

19.

Elkord, Eyad, Erik Alcantar-Orozco, Simon J. Dovedi, et al.. (2010). T regulatory cells in cancer: recent advances and therapeutic potential. Expert Opinion on Biological Therapy. 10(11). 1573–1586. 90 indexed citations

20.

Dovedi, Simon J., John A. Kirby, Barry R. Davies, Hing Y. Leung, & John D. Kelly. (2008). Celecoxib has Potent Antitumour Effects as a Single Agent and in Combination with BCG Immunotherapy in a Model of Urothelial Cell Carcinoma. European Urology. 54(3). 621–630. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact